His primary areas of investigation include Sickle cell anemia, Internal medicine, Anemia, Hemoglobinopathy and Surgery. His study in Sickle cell anemia is interdisciplinary in nature, drawing from both Hemolytic anemia, Transfusion therapy, Pediatrics and Stroke. The concepts of his Pediatrics study are interwoven with issues in Mortality rate, Epidemiology and Cohort study.
His work carried out in the field of Internal medicine brings together such families of science as Endocrinology, Cardiology, Gastroenterology, Immunology and Pathology. His Anemia research integrates issues from Randomized controlled trial, Disease, Hemoglobin SC Disease, Blood transfusion and Transplantation. In his work, Adverse effect, ABO blood group system, Alpha-thalassemia and Ineffective erythropoiesis is strongly intertwined with Thalassemia, which is a subfield of Hemoglobinopathy.
Elliott Vichinsky mainly focuses on Internal medicine, Sickle cell anemia, Thalassemia, Pediatrics and Disease. His research in Internal medicine is mostly concerned with Anemia. The Anemia study combines topics in areas such as Randomized controlled trial and Blood transfusion.
His Sickle cell anemia study incorporates themes from Hemolytic anemia, Hemoglobinopathy, Surgery and Stroke. His work on Newborn screening as part of general Pediatrics research is often related to In patient, thus linking different fields of science. His studies deal with areas such as Cell, Pharmacology and Intensive care medicine as well as Disease.
His primary areas of investigation include Internal medicine, Thalassemia, Disease, Pediatrics and Anemia. His Internal medicine research includes themes of Gastroenterology and Endocrinology. His work on Acute chest syndrome as part of general Disease study is frequently connected to Hope trial, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
Elliott Vichinsky interconnects Observational study, Sickle cell anemia, Epidemiology, Hydrops fetalis and Hemosiderosis in the investigation of issues within Pediatrics. His Sickle cell anemia research incorporates elements of Hemolytic anemia and Surrogate endpoint. His Anemia study also includes
Elliott Vichinsky mainly investigates Internal medicine, Thalassemia, Disease, Pediatrics and Transplantation. In Internal medicine, Elliott Vichinsky works on issues like Gastroenterology, which are connected to Surgery. Elliott Vichinsky has researched Thalassemia in several fields, including Young adult, Hematology, Non transfusion dependent thalassemia and Pathology.
His Hematology study combines topics from a wide range of disciplines, such as Silent stroke and Sickle cell anemia. His research integrates issues of Cell, Health care, Anemia, Newborn screening and Intensive care medicine in his study of Disease. His studies in Anemia integrate themes in fields like Prospective cohort study and Pharmacology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Prevention of a First Stroke by Transfusions in Children with Sickle Cell Anemia and Abnormal Results on Transcranial Doppler Ultrasonography
R J Adams;V C McKie;L Hsu;B Files.
The New England Journal of Medicine (1998)
Pain in sickle cell disease. Rates and risk factors.
Orah S. Platt;Bruce D. Thorington;Donald J. Brambilla;Paul F. Milner.
The New England Journal of Medicine (1991)
Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial.
Gaston Mh;Verter Ji;Woods G;Pegelow C.
The New England Journal of Medicine (1986)
Causes and Outcomes of the Acute Chest Syndrome in Sickle Cell Disease
E P Vichinsky;L D Neumayr;A N Earles;R Williams.
The New England Journal of Medicine (2000)
Effect of Hydroxyurea on Mortality and Morbidity in Adult Sickle Cell Anemia: Risks and Benefits Up to 9 Years of Treatment
Martin H. Steinberg;Martin H. Steinberg;Franca Barton;Oswaldo Castro;Charles H. Pegelow.
Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease.
Claudia R. Morris;Gregory J. Kato;Mirjana Poljakovic;Xunde Wang.
Acute Chest Syndrome in Sickle Cell Disease: Clinical Presentation and Course
Elliott P. Vichinsky;Lori A. Styles;Linda H. Colangelo;Elizabeth C. Wright.
Sickle cell disease
Gregory J Kato;Frédéric B Piel;Clarice D Reid;Marilyn H Gaston.
Nature Reviews Disease Primers (2018)
Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease.
Frances M. Gill;Lynn A. Sleeper;Steven J. Weiner;Audrey K. Brown.
Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood.
E P Vichinsky;A Earles;R A Johnson;Hoag.
The New England Journal of Medicine (1990)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: